(GSK:London Stock Exchange)
Patrick J. T. Vallance
President of Pharmaceuticals R&D, GlaxoSmithKline plc
|Age||Total Calculated Compensation||This person is connected to 49 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Dr. Patrick J. T. Vallance has been President of Pharmaceuticals R&D at GlaxoSmithKline plc since January 2012. Dr. served as Senior Vice President of Medicines Discovery and Development at GlaxoSmithKline plc since July 2010. Dr. Vallance served as Head of the Division of Medicine of Glaxosmithkline, Plc. Dr. Vallance manages one of the most research- intensive departments of medicine in the UK. He has over 20 years of experience of clinical medicine. He also maintains ...
980 Great West RoadPhone: 44 20 8047 5000
Brentford, Middlesex TW8 9GS
Board Members Memberships*
University Of London
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Robert J. Hugin MBA||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Inge G. Thulin||Chairman, Chief Executive Officer and President|
|Lars Rebien Sørensen||Chief Executive Officer and Member of Executive Management|
Novo Nordisk A/S
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|